Michael Loberg

Track

Insider profile

Currently holds a position at IGM Biosciences Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 24% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board IGM Biosciences Inc Aug. 1, 2018 -
Independent Director ArQule Inc Jan. 17, 2007 - Jan. 16, 2020
Director IGM Biosciences Inc Sept. 1, 2015 - Aug. 1, 2018
Michael Loberg's trades of IGM Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
146.93
Quantity 65,152 -5.5%
Value US$499,791
Transaction date
Purchase
Price
149.49
Quantity 19,626 +41.7%
Value US$1,197,389
Transaction date
Purchase
Price
144.92
Quantity 3,008 -2.9%
Value US$2,581,426
Transaction date
Purchase
Price
23.00
Quantity 21,739 +inf%
Value US$499,997
Transaction date
Purchase
Price
18.57
Quantity 5,000 +16.5%
Value US$92,867
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-10-03 2022-09-29
B Purchase
65,152 -5.5%
146.93
US$499,791 		65,152 -5.5% 146.93 US$499,791
2022-09-29 2022-09-28
B Purchase
19,626 +41.7%
149.49
US$1,197,389 		19,626 +41.7% 149.49 US$1,197,389
2022-09-29 2022-09-27
B Purchase
3,008 -2.9%
144.92
US$2,581,426 		3,008 -2.9% 144.92 US$2,581,426
2022-04-04 2022-04-01
B Purchase
21,739 +inf%
23.00
US$499,997 		21,739 +inf% 23.00 US$499,997
2019-09-20 2019-09-18
B Purchase
5,000 +16.5%
18.57
US$92,867 		5,000 +16.5% 18.57 US$92,867